SCHEMBL20047028

SCHEMBL20047028

COc1ccccc1-c1ccc2c(c1)CCN(S(=O)(=O)c1c(C)cc(I)cc1C)C2

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.47
CYP3A4 P08684 1/20 0.47
CYP2C19 P33261 1/20 0.47
NPSR1 Q6W5P4 1/20 0.47
PKM P14618 3/20 0.43
ALDH1A1 P00352 2/20 0.43
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
PTPRC P08575 1/20 0.41
PTPN1 P18031 1/20 0.41
CA7 P43166 1/20 0.40
AKR1C3 P42330 2/20 0.40
HSD17B3 P37058 1/20 0.40
CYP19A1 P11511 1/20 0.40
ABCB1 P08183 1/20 0.40
LMNA P02545 2/20 0.39
RAB9A P51151 1/20 0.39
POLB P06746 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
ESR2 Q92731 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20047169 0.92 SMN1; SMN2 (0.48) SMN1; SMN2CYP3A4CYP2C19NPSR1PKM
SCHEMBL20047030 0.86 KMT2A (0.51) MEN1KMT2APTPRCPTPN1AKR1C3
SCHEMBL20047027 0.83 PKM (0.51) SMN1; SMN2CYP3A4CYP2C19NPSR1PKM
SCHEMBL20047023 0.83 AKR1C3 (0.49) SMN1; SMN2CYP3A4CYP2C19NPSR1PKM
SCHEMBL20047022 0.79 MEN1 (0.43) SMN1; SMN2CYP3A4CYP2C19NPSR1MEN1
SCHEMBL20047032 0.78 KMT2A (0.47) MEN1KMT2AAKR1C3LMNAPOLB
SCHEMBL20047024 0.78 CHRM5 (0.41) SMN1; SMN2NPSR1PKMALDH1A1MEN1
SCHEMBL20047020 0.77 MEN1 (0.40) NPSR1MEN1KMT2AAKR1C3LMNA
SCHEMBL20047171 0.77 KMT2A (0.50) NPSR1MEN1KMT2AAKR1C3LMNA
SCHEMBL20047029 0.77 CYP11B1 (0.50) CYP3A4CYP2C19CYP11B1CYP11B2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017223514-A9 LXR INVERSE AGONISTS FOR TREATMENT OF CANCER SAINT LOUIS UNIVERSITY (US) 2018-04-12 WO disclosed